Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon

Int J Parasitol. 2010 Apr;40(5):515-9. doi: 10.1016/j.ijpara.2010.01.006. Epub 2010 Feb 4.

Abstract

A pilot field trial of the TSOL18 vaccine was undertaken in Cameroon. Two hundred and forty, 2-3 month-old piglets were distributed to 114 individual households in pairs. Vaccinated animals received three immunisations with 200 microg TSOL18 plus 5 mg Quil A and 30 mg/kg oxfendazole at the time of the second immunisation. Necropsies were undertaken when the pigs were approximately 12 months of age. Viable Taenia solium cysticerci were identified in 20 control pigs (prevalence 19.6%); no cysticerci were found in any of the vaccinated animals (P<0.0001). Combined application of TSOL18 vaccination and a single oxfendazole treatment in pigs may be a relatively simple and sustainable procedure that has the potential to control T. solium transmission in endemic areas and, indirectly, reduce the number of new cases of neurocysticercosis in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Animals
  • Anthelmintics / administration & dosage
  • Antigens, Helminth / immunology*
  • Benzimidazoles / administration & dosage
  • Cameroon
  • Immunization, Secondary / methods
  • Quillaja Saponins
  • Saponins / administration & dosage
  • Swine
  • Swine Diseases / prevention & control*
  • Taenia solium / immunology*
  • Taeniasis / prevention & control*
  • Vaccines / immunology*
  • Vaccines, Subunit / immunology

Substances

  • Adjuvants, Immunologic
  • Anthelmintics
  • Antigens, Helminth
  • Benzimidazoles
  • Quillaja Saponins
  • Saponins
  • TSOL-18 antigen
  • Vaccines
  • Vaccines, Subunit
  • Quil A
  • oxfendazole